Results 251 to 260 of about 147,027 (351)

The “Normal Range” of the Prothrombin Time Estimated by Quick's Method [PDF]

, 1959
G. I. C. Ingram, P. Armitage
openalex   +1 more source

Clinical liver transplantation [PDF]

, 1969
Brettschneider, L, Giles, G, Penn, I, Picache, R, Putnam, CW, Starzl, TE   +5 more
core   +1 more source

Endoscopic Closure Combined With the Endoscopic Submucosal Dissection Technique and Over‐the‐scope Clip for Chronic Aortoesophageal Fistula: A Case Report

DEN Open, Volume 6, Issue 1, April 2026.
ABSTRACT Aortoesophageal fistula (AEF) is a rare but life‐threatening condition. Initial management typically includes thoracic endovascular aortic repair (TEVAR) or aortic graft replacement to achieve hemostasis, followed by esophagectomy with aortic graft replacement and greater omentum wrapping to eliminate the source of infection.
Ryosuke Kawagoe, Toshiaki Narasaka, Takashi Mamiya, Masaaki Nishi, Kiichiro Tsuchiya   +4 more
wiley   +1 more source

[Vertebral fractures combined with prolonged activated partial prothrombin time: A case report]. [PDF]

Beijing Da Xue Xue Bao Yi Xue Ban
Bai X, He J, Lu S, Li C, Wang Y, Xiong J.   +5 more
europepmc   +1 more source

Rivaroxaban in Clinical Practice for Atrial Fibrillation With Special Reference to Prothrombin Time

, 2014
Shinya Suzuki, Takayuki Otsuka, Koichi Sagara, Hiroto Kano, Shunsuke Matsuno, Yuko Kato, Hideaki Takai, Tokuhisa Uejima, Yuji Oikawa, Kazuyuki Nagashima, Hajime Kirigaya, Junji Yajima, Hitoshi Sawada, Tadanori Aizawa, Takeshi Yamashita   +14 more
openalex   +2 more sources

A Case of Worsened Refractory Ascites due to Prednisolone Administration for Stricture Prevention after Endoscopic Submucosal Dissection for Extensive Early Esophageal Cancer: Case Report and Literature Review

DEN Open, Volume 6, Issue 1, April 2026.
ABSTRACT Endoscopic submucosal dissection (ESD) is widely used for early esophageal cancer, even in patients with liver cirrhosis (LC). Corticosteroids, administered orally or by local injection, are often used to prevent post‐ESD esophageal stricture. However, their safety in patients with decompensated LC and refractory ascites remains unclear. A man
Yuki Tamura, Masanori Sekiguchi, Kaho Honda, Yu Maruyama, Kenta Ito, Makiko Inoue, Mitsuhiko Shibasaki, Daichi Takizawa, Hirotaka Arai, Toshio Uraoka   +9 more
wiley   +1 more source

Proton Pump Inhibitor‐Induced Fundic Gland Polyps With Massive Bleeding Regressed on Alternative Histamine 2 Receptor Antagonist Therapy

DEN Open, Volume 6, Issue 1, April 2026.
Abstract We report a case of massive bleeding from proton pump inhibitor (PPI)‐induced fundic gland polyps (FGPs) that regressed after switching to a histamine‐2 receptor antagonist (H2RA). A 46‐year‐old man with antiphospholipid syndrome had been receiving warfarin and lansoprazole for 4 years.
Ryosuke Ikeda, Hiroaki Kaneko, Hiroki Sato, Yuto Matsuoka, Tomomi Hamaguchi, Aya Ikeda, Yoshihiro Goda, Soichiro Sue, Kuniyasu Irie, Shin Maeda   +9 more
wiley   +1 more source

Cardiogenic cerebral infarction after Takotsubo cardiomyopathy in a patient with catatonia: A case report

Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 1, March 2026.
Abstract Background Takotsubo cardiomyopathy (TTC) is a transient cardiac condition often triggered by an emotional or physical stress. TTC usually has a benign clinical course with full recovery. However, in rare cases, TTC is complicated by cardiogenic shock, left ventricular rupture, or ventricular thrombus.
Masaki Fujiwara, Yuto Yamada, Kazuhiro Osawa, Shinji Sakamoto, Masafumi Kodama   +4 more
wiley   +1 more source

Hubungan Jumlah Trombosit dengan Nilai Prothrombin Time dan Activated Partial Thromboplastin Time pada Pasien Persiapan Tindakan Operasi Caesar

, 2017
Wahdaniah Wahdaniah, Sri Tumpuk
openalex   +1 more source

Iptacopan for Immune Thrombocytopenia and Cold Agglutinin Disease: A Global Phase 2 Basket Clinical Trial

American Journal of Hematology, Volume 101, Issue 2, Page 242-254, February 2026.
ABSTRACT Iptacopan is a first‐in‐class, oral, selective inhibitor of complement factor B that has demonstrated positive efficacy across several complement‐driven diseases. Here we evaluate the efficacy and safety of iptacopan monotherapy in adult patients with primary immune thrombocytopenia (ITP) and primary cold agglutinin disease (CAD). We performed
Alexander Röth, Wilma Barcellini, Christine Ademokun, Junho Jang, Maria Luisa Lozano, David Valcarcel Ferreiras, Cristina Pascual‐Izquierdo, Shripad Chitnis, Sofiya Matviykiv, Alessandra Vitaliti, Chi Chen, Vasiliki Katsanou, Raghav Chawla, Hanny Al‐Samkari   +13 more
wiley   +1 more source